HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher Bishop Selected Research

Dyskinesias (Dyskinesia)

7/2022The effects of Vilazodone, YL-0919 and Vortioxetine in hemiparkinsonian rats.
1/2022The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats.
3/2021Dopamine D3 Receptor Plasticity in Parkinson's Disease and L-DOPA-Induced Dyskinesia.
1/2021Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats.
1/2021Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia.
1/2020Dopamine receptor cooperativity synergistically drives dyskinesia, motor behavior, and striatal GABA neurotransmission in hemiparkinsonian rats.
1/2020Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat.
1/2020Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian rats.
12/2019Neuroinflammation: Fanning the fire of l-dopa-induced dyskinesia.
1/2019Effects of Muscarinic Acetylcholine m1 and m4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher Bishop Research Topics

Disease

46Dyskinesias (Dyskinesia)
07/2022 - 11/2003
41Parkinson Disease (Parkinson's Disease)
07/2022 - 05/2006
2Movement Disorders (Movement Disorder)
01/2022 - 12/2013
2Neuroinflammatory Diseases
12/2019 - 01/2019
2Shock
11/2019 - 07/2013
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2022
1Diphtheria
01/2021
1Disease Progression
01/2021
1Gliosis
01/2021
1Neoplasms (Cancer)
11/2020
1Prostatic Neoplasms (Prostate Cancer)
11/2020
1Sleep Wake Disorders
01/2019
1Inflammation (Inflammations)
04/2016
1Asthma (Bronchial Asthma)
11/2015
1Seasonal Allergic Rhinitis (Hay Fever)
11/2015
1Eczema
11/2015
1Hypokinesia (Bradykinesia)
08/2014
1Tremor (Tremors)
08/2014
1Respiratory Sounds (Crackle)
05/2014

Drug/Important Bio-Agent (IBA)

45Levodopa (L Dopa)FDA LinkGeneric
07/2022 - 08/2005
29Dopamine (Intropin)FDA LinkGeneric
07/2022 - 08/2005
10Serotonin (5 Hydroxytryptamine)IBA
07/2022 - 03/2003
95-HT1A Serotonin ReceptorIBA
11/2013 - 05/2006
7Oxidopamine (6 Hydroxydopamine)IBA
01/2021 - 05/2006
5SK&F 81297IBA
01/2019 - 12/2008
3Vilazodone HydrochlorideIBA
07/2022 - 11/2018
3Acetylcholine (Acetylcholine Chloride)FDA Link
01/2021 - 01/2018
3Cholinergic Agents (Cholinergics)IBA
01/2021 - 01/2018
3salicylhydroxamic acid (SHAM)IBA
01/2021 - 06/2011
3Dopamine Receptors (Dopamine Receptor)IBA
01/2020 - 07/2007
3Glutamic Acid (Glutamate)FDA Link
11/2017 - 06/2011
2Dopamine D3 ReceptorsIBA
03/2021 - 01/2021
2Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2016
2Phosphotransferases (Kinase)IBA
01/2021 - 11/2013
2gamma-Aminobutyric Acid (GABA)IBA
01/2020 - 01/2016
22,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)IBA
01/2020 - 01/2017
2QuinpiroleIBA
01/2019 - 07/2015
2Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2018 - 07/2013
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2018 - 01/2016
2Pharmaceutical PreparationsIBA
09/2017 - 04/2016
2Immunoglobulin E (IgE)IBA
11/2015 - 05/2014
2Dopamine D1 Receptors (Dopamine D1 Receptor)IBA
09/2009 - 05/2006
2hydroxide ionIBA
05/2009 - 12/2008
11- (1- benzyl- 4- hydroxypiperidin- 4- ylmethyl)- 2(1H)- pyridinoneIBA
07/2022
1VortioxetineIBA
07/2022
1Amantadine (Aman)FDA LinkGeneric
01/2022
1Excitatory Amino Acid AntagonistsIBA
01/2022
1EnzymesIBA
01/2021
1Protein Kinases (Protein Kinase)IBA
01/2021
1Biological ProductsIBA
01/2021
1urotensin IIIBA
01/2021
13,4,4a,10b- tetrahydro- 4- propyl- 2H,5H- (1)benzopyrano(4,3- b)- 1,4- oxazin- 9- olIBA
01/2020
1TropicamideFDA LinkGeneric
01/2019
1AutoreceptorsIBA
01/2019
1Trihexyphenidyl (Artane)FDA LinkGeneric
01/2019
1Serotonin ReceptorsIBA
11/2018
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
11/2017
1Glutamate Receptors (Glutamate Receptor)IBA
11/2017
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
11/2017
1AntioxidantsIBA
09/2017
1NeurotoxinsIBA
09/2017
1ropinirole (Requip)FDA LinkGeneric
09/2017
13- chloro- 4- fluorophenyl- (4- fluoro- 4- (((5- methyl- 6- methylaminopyridin- 2- ylmethyl)amino)methyl)piperidin- 1- yl)methanoneIBA
01/2017
13- chloro- 4- fluorophenyl- (4- fluoro- 4- (((5- methylpyrimidin- 2- ylmethyl)amino)methyl)piperidin- 1- yl)methanoneIBA
01/2017
1vanoxerine (I 893)IBA
11/2016
1CitalopramFDA LinkGeneric
11/2016
1nisoxetineIBA
11/2016
1Naproxen (Naprosyn)FDA LinkGeneric
04/2016
1Clomipramine (Anafranil)FDA LinkGeneric
03/2016
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
03/2016
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
01/2016
1AllergensIBA
11/2015
1Therapeutic UsesIBA
08/2015
1atipamezoleIBA
08/2015
1Clonidine (ST 155)FDA LinkGeneric
08/2015
1beta Adrenergic ReceptorsIBA
07/2015
1Propranolol (Inderal)FDA LinkGeneric
07/2015
1Biomarkers (Surrogate Marker)IBA
11/2013
1Interleukin-1 (Interleukin 1)IBA
07/2013
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2013
1Dihydrotachysterol (AT 10)IBA
06/2013
1Dopamine Agonists (Dopamine Agonist)IBA
06/2013
1alpha- (4- fluorophenyl)- 4- (5- fluoro- 2- pyrimidinyl)- 1- piperazine butanolIBA
06/2013
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
05/2013
1Tuberculin (PPD)IBA
05/2013
1Messenger RNA (mRNA)IBA
05/2013
1pre-prodynorphinIBA
05/2013
1ApomorphineFDA Link
09/2012
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
09/2012
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
09/2012
1Adrenergic Antagonists (Antiadrenergic Agents)IBA
01/2012
1Adrenergic Receptors (Adrenergic Receptor)IBA
06/2011

Therapy/Procedure

18Therapeutics
07/2022 - 11/2003
3Drug Therapy (Chemotherapy)
08/2014 - 05/2006
1Image-Guided Radiotherapy
11/2020
1Radiotherapy
11/2020
1Foot Orthoses
11/2019
1Transcranial Magnetic Stimulation
01/2016
1Injections
11/2013
1Denervation
01/2012